<DOC>
	<DOCNO>NCT02189122</DOCNO>
	<brief_summary>The investigator compare effect rapid release aspirin NHP-544C prostacyclin response intravenous bradykinin .</brief_summary>
	<brief_title>Comparative Effects Aspirin NHP-544C</brief_title>
	<detailed_description />
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Kininogens</mesh_term>
	<mesh_term>Bradykinin</mesh_term>
	<criteria>1 . Ages 18 55 year , inclusive 2 . No significant medical issue without significant abnormal finding baseline physical examination 3 . Body mass index ( BMI ) 18.0 30.0kg/m2 ( weight ( kg ) / [ height ( ) ] 2 ) 4 . For woman negative pregnancy test Period 1 , Day 1 , surgically sterilize , least two year postmenopausal prior randomization . Females childbearing potential must practice acceptable method birth control eligible . Acceptable form birth control include : condom plus spermicide condom plus form birth control include hormonal method ( IUD , patch , ring , implant , injectable ) , sterilization partner , nonhormonal IUD . The use oral contraceptive allow study , subject must stable dose 30 day prior trial throughout four dose period 5 . Ability understand requirement study willingness comply study procedures 1 . Clinically significant relevant medical history ( include failure major organ system ) current medical illness , deem Principal Investigator unsuitable participate study 2 . Participation investigational drug study within 30 day prior CRC admission 3 . Use aspirin NSAID within 14 day Day 1 study . All medication , prescription ( exception contraceptive ) , overthecounter ( OTC ) , herbal , vitamin supplement must discontinue 7 day prior Day 1 . If subject take prescription medication , OTC medication direction health care provider , provider must confirm acceptable stop dose duration study 4 . History metabolic , renal , hepatic , hemorrhagic stroke , gastrointestinal bleed , cardiovascular disease , central nervous system disorder , peptic ulcer disease chronic bleeding disorder 5 . History gastrointestinal disorder could result incomplete absorption study drug 6 . Malignancy , neurologic psychiatric disorder 7 . Abnormal laboratory value ( ) determine clinically significant ( opinion Investigator ) 8 . History illicit drug abuse past year current evidence abuse opinion investigator 9 . Pregnancy lactation 10 . Acute illness within 1 week CRC admission 11 . Significant loss blood blood plasma donation within 30 day drug administration 12 . Hypersensitivity allergy NSAIDs , aspirin , ethylcellulose , polyvidone , castor oil , magnesium stearate , tartaric acid , colloidal anhydrous silica , talc , gelatin , titanium dioxide , erythrosine , indigotin 13 . History aspirin resistance 14 . History alcohol abuse within past year . Current alcohol use exceed 14 standard alcoholic drink per week . A drink define 1.5 ounce ( oz . ) liquor , 12 oz . beer , 6 oz . wine 15 . Alcohol consumption within 3 day Day 1 16 . Difficulty swallow oral medication 17 . Consumption coffee caffeinecontaining beverage exceed equivalent five 8oz cup coffee per day average</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>